Arrowhead Pharmaceuticals, Inc. (ARWR)
62.38
+0.83
(+1.35%)
USD |
NASDAQ |
Feb 12, 16:00
60.87
-1.51
(-2.42%)
After-Hours: 06:00
Arrowhead Pharmaceuticals Free Cash Flow : 327.01M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Sarepta Therapeutics, Inc. | -401.63M |
| Sanofi | 12.54B |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| Eli Lilly & Co. | 6.436B |
| Cidara Therapeutics, Inc. | -132.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 13.48M |
| Cash from Investing (Quarterly) | -23.74M |
| Cash from Financing (Quarterly) | -14.75M |
| Free Cash Flow Per Share (Quarterly) | 0.0805 |
| Free Cash Flow to Equity (Quarterly) | 57.25M |
| Free Cash Flow to Firm (Quarterly) | 33.81M |
| Free Cash Flow Yield | 3.81% |